Months of hitting protein targets, sleeping right, showing up when you didn't want to
This study builds on Ro's strong foundation of clinical research, including eight abstracts that the company presented at ObesityWeek 2025 in November, spanning topics from the use of AI to improve the patient experience, such as an evaluation of Ro's LLM-enabled adverse event reporting tool, to outcomes among patients treated with GLP-1s, such as those with osteoarthritis
This is where a licensed provider reviews your medical information, evaluates your eligibility, and makes the clinical decision about whether to prescribe GLP-1 medication
1a, b and Supplementary Fig
One product contained endotoxin a toxic substance produced by bacteria suggesting that it was contaminated with microbes
Extracellular NCOA4 is a mediator of septic death by activating the AGER-NFKB pathway